MARKET

AMRS

AMRS

Amyris
NASDAQ

Real-time Quotes | Nasdaq Last Sale

15.07
+0.53
+3.65%
After Hours: 15.07 0 0.00% 16:42 07/28 EDT
OPEN
14.50
PREV CLOSE
14.54
HIGH
15.37
LOW
14.47
VOLUME
2.13M
TURNOVER
--
52 WEEK HIGH
23.42
52 WEEK LOW
1.875
MARKET CAP
4.45B
P/E (TTM)
-6.5199
1D
5D
1M
3M
1Y
5Y
Alcoa becomes top materials gainer on strong Q2 results; Piedmont Lithium at bottom
Basic material stocks closed out the trading week on a positive note, with iShares U.S. Basic Materials (IYM) +1.33% and Materials Select Sector SPDR ETF (XLB) +0.79%.Lumber futures saw a surge this week
Seekingalpha · 4d ago
Understanding Amyris's Unusual Options Activity
Shares of Amyris (NASDAQ:AMRS) saw some unusual options activity on Friday. Following the unusual option alert, the stock price moved down to $15.05.
Benzinga · 5d ago
Amyris forms new menopause-focused consumer brand
Biotechnology company Amyris (AMRS) has formed a consumer brand focused on menopause wellness products with Naomi Watts, actress and co-founder of beauty brand ONDA Beauty.The new brand is set to
Seekingalpha · 6d ago
Amyris Partners With Naomi Watts To Launch Science-Backed Wellness Brand Focused On Menopause
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced a partnership with Naomi W...
PR Newswire · 6d ago
Amyris To Host Second Quarter 2021 Financial Results Conference Call On August 5
Amyris, Inc., (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it will issue its fi...
PR Newswire · 07/21 12:00
AMRS Stock: Why Biotech Stock Amyris Is Shooting Higher Today
Investor Place · 07/19 19:52
The Latest Picks And Pans From Barron's: Dividend Kings, Roundtable Picks, SAP And More
The cover story in this weekend's Barron's offers 42 bargain stock picks from the Barron's Roundtable. Other featured articles discuss disappearing Chinese stocks, the next big thing in biotech and themes to watch for in big tech earnings.
Benzinga · 07/18 22:46
Synthetic Biology Could Be the Next Big Thing. Here’s How to Play It.
marketwatch.com · 07/16 23:42
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AMRS. Analyze the recent business situations of Amyris through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AMRS stock price target is 24.00 with a high estimate of 35.00 and a low estimate of 19.00.
EPS
Institutional Holdings
Institutions: 196
Institutional Holdings: 106.39M
% Owned: 36.00%
Shares Outstanding: 295.56M
TypeInstitutionsShares
Increased
51
14.18M
New
54
6.55M
Decreased
34
10.90M
Sold Out
26
5.70M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Commodity Chemicals
-0.02%
Chemicals
+0.11%
Key Executives
Non-Executive Chairman/Independent Director
Geoffrey Duyk
Chief Executive Officer/President/Director
John Melo
Chief Financial Officer/Chief Administrative Officer
Han Kieftenbeld
Chief Operating Officer
Eduardo Alvarez
General Counsel/Secretary
Nicole Kelsey
Other
Francisco Costa
Director
Philip Eykerman
Independent Director
John Doerr
Independent Director
Frank Kung
Independent Director
James Mccann
Independent Director
Steven Mills
Independent Director
Lisa Qi
Independent Director
Julie Washington
Independent Director
Patrick Yang
No Data
About AMRS
Amyris, Inc. is an industrial biotechnology company. The Company is primarily focused on applying its technology platform to engineer, manufacture and sell high performance, natural, sustainably-sourced products into the Health & Wellness, Clean Beauty, and Flavor and Fragrance markets. Its technology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into volume, high-value ingredients. Its biotechnology platform and industrial fermentation process replace existing complex and expensive manufacturing processes. The Company’s platform is used to design, build, optimize and upscale strains producing eight distinct molecules at commercial volumes, to more than 15 commercial ingredients.

Webull offers kinds of Amyris Inc stock information, including NASDAQ:AMRS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AMRS stock methods without spending real money on the virtual paper trading platform.